Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy
Stenotrophomonas maltophilia is a commensal and an emerging pathogen earlier noted in
broad-spectrum life threatening infections among the vulnerable, but more recently as a …
broad-spectrum life threatening infections among the vulnerable, but more recently as a …
Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options
Stenotrophomonas maltophilia is a Gram-negative, biofilm-forming bacterium. Although
generally regarded as an organism of low virulence, S. maltophilia is an emerging multi …
generally regarded as an organism of low virulence, S. maltophilia is an emerging multi …
[HTML][HTML] Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis
Objectives Stenotrophomonas maltophilia (S. maltophilia), an opportunistic pathogen,
causes infection in patients undergoing immunosuppressive therapy, mechanical …
causes infection in patients undergoing immunosuppressive therapy, mechanical …
[HTML][HTML] Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese …
Extensively drug-resistant (XDR) Gram-negative bacilli (GNB) are defined as bacterial
isolates susceptible to two or fewer antimicrobial categories. XDR-GNB mainly occur in …
isolates susceptible to two or fewer antimicrobial categories. XDR-GNB mainly occur in …
Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone–resistant strains
EJ Kim, YC Kim, JY Ahn, SJ Jeong, NS Ku… - BMC infectious …, 2019 - Springer
Background Stenotrophomonas maltophilia is an important nosocomial pathogen. This
pathogen has intrinsic or acquired resistance to a number of antibiotics classes …
pathogen has intrinsic or acquired resistance to a number of antibiotics classes …
Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections
E Hand, H Davis, T Kim, B Duhon - Journal of Antimicrobial …, 2016 - academic.oup.com
Objectives Stenotrophomonas maltophilia is a Gram-negative bacillus intermittently isolated
from hospitalized patients. Trimethoprim/sulfamethoxazole is considered the treatment of …
from hospitalized patients. Trimethoprim/sulfamethoxazole is considered the treatment of …
Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis
N Bostanghadiri, M Sholeh, T Navidifar… - Annals of Clinical …, 2024 - Springer
Abstract Introduction Infections caused by Stenotrophomonas maltophilia are clinically
important due to its intrinsic resistance to a broad range of antibiotics. Therefore, selecting …
important due to its intrinsic resistance to a broad range of antibiotics. Therefore, selecting …
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient
A Pompilio, V Crocetta, D Ghosh… - Frontiers in …, 2016 - frontiersin.org
The present study was carried out to understand the adaptive strategies developed by
Stenotrophomonas maltophilia for chronic colonization of the cystic fibrosis (CF) lung. For …
Stenotrophomonas maltophilia for chronic colonization of the cystic fibrosis (CF) lung. For …
[HTML][HTML] Emergence of concurrent levofloxacin-and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity …
RX Wu, CM Yu, ST Hsu, CH Wang - Journal of Microbiology, Immunology …, 2022 - Elsevier
Background The emergence of concurrent levofloxacin-and trimethoprim/sulfamethoxazole
(TMP/SMX)-resistant Stenotrophomonas maltophilia (LTSRSM) in Taiwan is becoming a …
(TMP/SMX)-resistant Stenotrophomonas maltophilia (LTSRSM) in Taiwan is becoming a …
Treatment, clinical outcomes, and predictors of mortality among a national cohort of hospitalized patients with Stenotrophomonas maltophilia infection
Objectives To analyze treatment, clinical outcomes, and predictors of inpatient mortality in
hospitalized patients with Stenotrophomonas maltophilia infection. Study design …
hospitalized patients with Stenotrophomonas maltophilia infection. Study design …